WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today criticized the trade association for the greediest, most profitable industry on the planet for hypocritically crying out for so-called “drug price fairness” in a full-page ad about the 340B drug pricing program that ran earlier this week in the Washington Post. The cynical ad was placed by the Pharmaceutical … [Read more…]
BEIJING–(BUSINESS WIRE)–InnoCare (HKEX: 09969) today announced that tafasitamab (Minjuvi®) in combination with lenalidomide has been approved by the Health Commission and Medical Products Administration of Hainan Province, under the early access program in Boao Lecheng International Medical Tourism Pilot Zone, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP), centered at Children’s Hospital Los Angeles (CHLA), presented its 2022 Symposium entitled “Patient Impact, Patient Voice,” bringing innovators, clinicians and patient families together virtually to discuss the importance of better integrating patients and their perspectives into the design, development and research of … [Read more…]
ONTARIO, Calif.–(BUSINESS WIRE)–#LA500—Dr. Prem Reddy, Chairman, President and CEO of Prime Healthcare, has once again been named among the LA500 by the Los Angeles Business Journal, an annual list of the most influential leaders and executives in Los Angeles who demonstrate “driving innovation, creativity, community and industry.” This year marks the third year in a … [Read more…]
GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, … [Read more…]
PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide … [Read more…]
Total Enterprise Value of Approximately $1.25 Billion AUSTIN, Texas–(BUSINESS WIRE)–Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, … [Read more…]
CHICAGO–(BUSINESS WIRE)–Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will report its financial results for the three months ended June 30, 2022 after the close of stock market hours on Thursday, August 4, 2022. Allscripts management plans to host a conference call and webcast to discuss the company’s earnings at 4:30 p.m. Eastern Time that same day. … [Read more…]
BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event … [Read more…]
Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expected Companies to host conference call today, July 21, 2022, at 5:00 p.m. ET SEATTLE & SAN DIEGO–(BUSINESS WIRE)–Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”) today announced that the companies … [Read more…]
